An official website of the United States government
Number of reported cases* and estimated infections† of acute hepatitis B — United States, 2015–2022
Source: CDC, National Notifiable Diseases Surveillance System.
* Reported confirmed cases. For the case definition, see Acute Hepatitis B.
† The number of estimated viral hepatitis infections was determined by multiplying the number of reported cases that met the classification criteria for a confirmed case by a factor that adjusted for underascertainment and underreporting. The 95% bootstrap confidence intervals for the estimated number of infections are displayed in the Appendix.
* Reported confirmed cases. For the case definition, see Acute Hepatitis B.
† The number of estimated viral hepatitis infections was determined by multiplying the number of reported cases that met the classification criteria for a confirmed case by a factor that adjusted for underascertainment and underreporting. The 95% bootstrap confidence intervals for the estimated number of infections are displayed in the Appendix.
During 2022, the number of reported cases of acute hepatitis B was 2,126, which corresponds to 13,800 estimated infections after adjusting for case underascertainment and underreporting.1 After a decade of stable rates, the rate of acute hepatitis B decreased in 2020 and remained stable in 2021 and 2022. Although changes in health care-seeking behavior and testing during the COVID-19 pandemic could have affected recent trends, the stability of the rate through 2022 suggests some reduction in hepatitis B virus (HBV) transmission, which may be unrelated to disruptions during the COVID-19 pandemic.
Source:
- Klevens RM, Liu S, Roberts H, et al. Estimating acute viral hepatitis infections from nationally reported cases. Am J Public Health 2014;104:482. PMC3953761.
Hepatitis B figures and tables
- Figure 2.1. Number of reported cases and estimated infections of acute hepatitis B — United States, 2015–2022
- Figure 2.2. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2021–2022
- Figure 2.3. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2022
- Figure 2.4. Rates of reported cases of acute hepatitis B, by age group — United States, 2007–2022
- Figure 2.5. Rates of reported cases of acute hepatitis B, by sex — United States, 2007–2022
- Figure 2.6. Rates of reported cases of acute hepatitis B, by race/ethnicity — United States, 2007–2022
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B — United States, 2022
- Figure 2.8. Rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2018–2022
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B, by demographic characteristics — United States, 2018–2022
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B — United States, 2022
- Table 2.4. Number of newly reported cases of perinatal hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B, by demographic characteristics — United States, 2022
- Table 2.7. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 2.8. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022